Myeloperoxidase gene-463G > A polymorphism and premature coronary artery disease

Genetics and Molecular Biology

Volumn 32, Issue 2, 2009, Pages 260-263

  Chen, Zhong ^a   Yin, Quanzhong ^b   Ma, Genshan ^a   Zhang, Hua ^b   Zheng, Ruolong ^b   Wang, Jiahong ^a   Gao, Chunheng ^b  

^a AFFILIATED ZHONGDA HOSPITAL OF SOUTHEAST UNIVERSITY   (China)

^b JIANGYIN PEOPLE S HOSPITAL   (China)

Author keywords

Myeloperoxidase; Premature coronary artery disease; Protective genetic polymorphism

Indexed keywords

GLUCOSE; LIPID; MYELOPEROXIDASE;

ADULT; ARTICLE; BODY MASS; CHINESE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DNA POLYMORPHISM; FAMILY HISTORY; FEMALE; GENE FREQUENCY; GENE SEQUENCE; GENOTYPE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; LIGASE CHAIN REACTION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREVALENCE; RISK FACTOR; SMOKING;

EID: 66649109970     PISSN: 14154757     EISSN: 16784685     Source Type: Journal    
DOI: 10.1590/s1415-47572009005000035     Document Type: Article

References (19)

1. Asselbergs FW, Reynolds WF, Cohen-Tervaert JW, Jessurun GA and Tio RA (2004) Myeloperoxidase polymorphism related to cardiovascular events in coronary artery disease. Am J Med 116:429-430.
2. Austin GE, Lam L, Zaki SR, Chan WC, Hodge T, Hou J, Swan D, Zhang W, Racine M, Whitsett C, et al. (1993) Sequence comparison of putative regulatory DNA of the 5′ flanking region of the myeloperoxidase gene in normal and leukemic bone marrow cells. Leukemia 7:1445-1450.
3. Bostom AG, Cupples LA, Jenner JL, Ordovas JM, Seman LJ, Wilson PW, Schaefer EJ and Castelli WP (1996) Elevated plasma lipoprotein (a) and coronary artery disease in man aged 55 years and younger. A prospective study. JAMA 276:544-546.
4. Brennan ML and Hazen SL (2003) Emerging role of myeloperoxidase and oxidant stress markers in cardiovascular risk assessment. Curr Opin Lipidol 14:353-359.
5. Brennan ML, Penn MS, Van Lente F, Nambi V, Shishehbor MH, Aviles RJ, Goormastic M, Pepoy ML, McErlean ES, Topol EJ, et al. (2003) Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med 349:1595-1604.
6. Chevrier I, Stücker I, Houllier AM, Cenée S, Beaune P, Laurent-Puig P and Loriot MA (2003) Myeloperoxidase: New polymorphisms and relation with lung cancer risk. Pharmacogenetics 13:729-739.
7. Chevrier I, Tregouet DA, Massonnet-Castel S, Beaune P and Loriot MA (2006) Myeloperoxidase genetic polymorphisms modulate human neutrophil enzyme activity: Genetic determinants for atherosclerosis. Atherosclerosis 188:150-154.
8. Denzler KL, Levin WJ, Lee JJ and Lee NA (1997) The murine eosinophil peroxidase maps to chromosome 11. Mamm Genome 8:381-382.
9. Favis R, Day JP, Gerry NP, Phelan C, Narod S and Barany F (2000) Universal DNA array detection of small insertions and deletions in BRCA1 and BRCA2. Nat Biotechnol 18:561-564.
10. Kareinen A, Viitanen L, Halonen P, Lehto S and Laakso M (2001) Cardiovascular risk factors associated with insulin resistance cluster in families with early-onset coronary artery disease. Arterioscler Thromb Vasc Biol 21:1346-1352.
11. Ndrepepa G, Braun S, Mehilli J, von Beckerath N, Schömig A and Kastrati A (2008) Myeloperoxidase level in patients with stable coronary artery disease and acute coronary syndromes. Eur J Clin Invest 38:90-96.
12. Nicholls SJ and Hazen SL (2005) Myeloperoxidase and cardiovascular disease. Arterioscler Thromb Vasc Biol 25:1102-1111.
13. Nikpoor B, Turecki G, Fournier C, Théroux P and Rouleau GA (2001) A functional myeloperoxidase polymorphic variant is associated with coronary artery disease in French-Canadians. Am Heart J 142:336-339.
14. Rutgers A, Heeringa P, Giesen JE, Theunissen RT, Jacobs H and Tervaert JW (2003) Neutrophil myeloperoxidase activity and the influence of two single-nucleotide promoter polymorphisms. Br J Haematol 123:536-538.
15. Schaefer EJ, Genest Jr JJ, Ordovas JM, Salem DN and Wilson PW (1994) Familial lipoprotein disorders and premature coronary artery disease. Atherosclerosis 108:S41-S54.
16. Stefanescu A, Braun S, Ndrepepa G, Koppara T, Pavaci H, Mehilli J, Schömig A, Kastrati A, Stefanescu A, Braun S, et al. (2008) Prognostic value of plasma myeloperoxidase concentration in patients with stable coronary artery disease. Am Heart J 155:356-360.
17. Sugiyama S, Okada Y, Sukhova GK, Virmani R, Heinecke JW and Libby P (2001) Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes. Am J Pathol 158:879-891.
18. WHO (1990) MONICA Manual; CVD/MNC. World Health Organization, Geneva.
19. Xiao Z, Xiao J, Jiang Y, Zhang S, Yu M, Zhao J, Wei D and Cao H (2006) A novel method based on ligase detection reaction for low abundant YIDD mutants detection in hepatitis B virus. Hepatol Res 34:150-155.